Structure-Based Drug Design and Virtual Screening bring together high-throughput crystallography and NMR, computational advances in docking algorithms and virtual screening, and traditional techniques of high-throughput screening and combinatorial chemistry to increase the efficiency and speed of the drug discovery and development process. Cambridge Healthtech Institute’s fifth annual Structure-Based Drug Design conference continues to deliver the latest developments in de novo, NMR-based, and crystallography-based drug design, while the second annual Virtual Screening conference brings new innovation and recent results in computational methods for smarter drug discovery and development. Attend both meetings to gain insight into smarter drug design and development from methods, case studies and technologies presented by pharmaceutical, academic and biotechnology experts.